Value proposition
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and MedtechOriginal language
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
https://www.kurmapartners.com/en
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | HCVC Venture Capital and Private Equity Principals | Other 7 Dec 2024 | | |
 | Alven Venture Capital and Private Equity Principals | Other 7 Dec 2024 | | |
 | SHARPSTONE | Other 10 Dec 2024 | | |
 | Debiopharm Pharmaceutical Manufacturing, biotech, deeptech | Other 28 Nov 2024 | | |
 | BioLabs Biotechnology Research | Other 28 Nov 2024 | | |
 | Les Echos Writing and Editing | Other 28 Nov 2024 | | |
 | Techmind Financial Services | Other 28 Nov 2024 | | |
 | Founders Future Software Development | Other 3 Dec 2024 | | |
 | Galion.exe it services | Other 29 Nov 2024 | | |
 | Kickston Financial Services | Other 12 Nov 2024 | | |